Moderna, Inc. (1MRNA)
MTA
Real-time Data
07:00 AM
Day's Range
112.1452 wk Range
19.38Profile - 1MRNA - Moderna, Inc.
Profile
Mic Code
XMIL
Sector
Healthcare
Industry
Biotechnology
Employees
4.70K
Moderna, Inc. is a biotechnology company focused on messenger RNA (mRNA) medicines and vaccines. Its portfolio centers on products for respiratory and infectious diseases, including COVID-19 and RSV vaccines, alongside a pipeline that extends into oncology, rare diseases, autoimmune disorders, and other therapeutic areas. The company uses its mRNA platform to design medicines that instruct cells to produce proteins with preventive or therapeutic potential, making it an important developer in modern biopharmaceutical research. Moderna, Inc. also maintains integrated manufacturing capabilities and commercial operations that support the development, production, and distribution of its current products and clinical programs. Headquartered in Cambridge, Massachusetts, and founded in 2010, Moderna, Inc. plays a notable role in advancing mRNA-based treatments and vaccines across global healthcare markets.
Profile Details
Type
Common Stock
Address
325 Binney Street
City
Cambridge
State
MA
Zip
02142
Country
United States
Phone
617 714 6500
Key Executives - 1MRNA - Moderna, Inc.
Key executives
Cross Listings - 1MRNA - Moderna, Inc.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
